A new statewide poll suggests Marylanders are more than ready to yank a tax perk for Big Pharma, putting a consumer-facing drug advertising break squarely in the crosshairs in Annapolis. Supporters say ending the deduction would free up badly needed cash for Medicaid and the state’s insurance marketplace at a time when lawmakers are wrestling with how to keep coverage affordable and enrollment strong. The idea has quickly turned into a tug-of-war between health advocates hunting for revenue and industry groups warning of legal headaches and economic blowback.
According to WBAL, an Opinion Works survey found 73% of registered Maryland voters say health care should be available and affordable, and that nearly three-quarters support legislation to scrap the tax break. Sponsors say the move would steer roughly $24 million a year toward Medicaid and the Maryland Health Benefit Exchange. Reporting from WBAL notes the state would put about $5 million into the Department of Health to strengthen Medicaid eligibility operations, with the rest flowing to subsidies on the ACA marketplace. “So that we could use the $24 million that we received every year to make sure Marylanders have the health care they need,” said Vinny DeMarco, president of Health Care for All, as reported by WBAL.
Where supporters say the money would go
Backers of the proposal say the redirected dollars would help stabilize the system rather than just plug holes. They point to plans to shore up eligibility operations and expand premium assistance for people buying coverage through Maryland Health Connection, the state’s marketplace, according to the Maryland Health Benefit Exchange. The exchange has highlighted state-funded subsidies and recent enrollment gains as tools that have helped keep premiums from spiking after changes to federal premium assistance. Advocates argue that carefully targeted funding can make the marketplace more durable for low and middle-income households.
Industry pushback and legal questions
Opponents counter that the proposal unfairly zeroes in on a single industry and could open the door to expensive court fights. Similar ideas at the federal level, which would deny tax deductions for direct-to-consumer drug advertising, have already led broadcasters and trade groups to raise alarms about lost revenue for local media and the thorny business of regulating commercial speech, as reported in The Seattle Times. Tax analysts caution that using the income tax code to police advertising is a blunt instrument that could draw First Amendment challenges and produce uneven economic effects, according to the Tax Policy Center.
What comes next in Annapolis
The measure still has to make it through the full General Assembly gauntlet before it can become law. That means committee hearings, debates, and floor votes in both chambers, followed by the governor’s signature, a process laid out in the Maryland manual on the legislative process. Along the way, lawmakers will have to decide whether the projected revenue is worth the legal risks and any fallout for broadcasters and local media outlets. Supporters say even relatively modest sums could add resilience to enrollment systems and subsidy programs, while skeptics argue the ripple effects in the broader market are far from fully mapped out.
For now, the poll gives proponents a handy talking point in committee rooms: a clear majority of Maryland voters say they prioritize affordable health care, according to the survey. Legislators and lobbyists on both sides are bracing for a lively fight in Annapolis as the session rolls on.
